Related Experiment Video
Updated: Oct 15, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
The Clinical outcomes, healthcare resource utilization, and related costs (COHERENT) model. Application in heart
Héctor Bueno1, José L Bernal2, Víctor Jiménez-Jiménez3
1Grupo de Investigación Cardiovascular Multidisciplinaria Traslacional, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain; Servicio de Cardiología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain; Facultad de Medicina, Universidad Complutense, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain.
Insights
The Clinical outcomes, healthcare resource utilization and related costs (COHERENT) model visually displays composite endpoints and costs. This new tool effectively compares patient groups and cohorts, aiding clinical trials and healthcare benchmarking.
Area of Science:
- Health Services Research
- Clinical Epidemiology
- Health Economics
Background:
- Composite endpoints are crucial in clinical research but have limitations.
- Visualizing endpoint components (incidence, timing, duration) and costs is challenging.
- The Clinical outcomes, healthcare resource utilization and related costs (COHERENT) model offers a novel visual approach.
Purpose of the Study:
- To validate the COHERENT model in a real-world patient cohort.
- To assess the model's ability to display composite endpoint components and associated costs.
- To evaluate the COHERENT model's utility for comparing patient groups and healthcare systems.
Main Methods:
- Developed a color graphic system to display patient clinical status and costs over time.
- Hierarchically coded mutually exclusive clinical situations.
- Tested the system on 1126 acute heart failure patients across 25 hospitals, analyzing 30-day outcomes and costs.
Main Results:
- The COHERENT model visualized 30-day patient trajectories (e.g., alive at home, in ED, hospitalized, deceased).
- Significant differences in outcomes and costs were observed between patient groups, hospitals, and healthcare systems.
- Daily and cumulative healthcare costs were calculated, totaling over €4.8 million for the cohort.
Conclusions:
- The COHERENT model provides an interpretable visual display for composite endpoints and costs.
- It facilitates comparisons across patient groups and cohorts.
- The model is a promising tool for clinical trials, observational studies, benchmarking, and value-based healthcare.
Introduction And Objectives:
Composite endpoints are widely used but have several limitations. The Clinical outcomes, healthcare resource utilization and related costs (COHERENT) model is a new approach for visually displaying and comparing composite endpoints including all their components (incidence, timing, duration) and related costs. We aimed to assess the validity of the COHERENT model in a patient cohort.
Methods:
A color graphic system displaying the percentage of patients in each clinical situation (vital status and location: at home, emergency department [ED] or hospital) and related costs at each time point during follow-up was created based on a list of mutually exclusive clinical situations coded in a hierarchical fashion. The system was tested in a cohort of 1126 patients with acute heart failure from 25 hospitals. The system calculated and displayed the time spent in each clinical situation and health care resource utilization-related costs over 30 days.
Results:
The model illustrated the times spent over 30 days (2.12% in ED, 23.6% in index hospitalization, 2.7% in readmissions, 65.5% alive at home, and 6.02% dead), showing significant differences between patient groups, hospitals, and health care systems. The tool calculated and displayed the daily and cumulative health care-related costs over time (total, €4 895 070; mean, €144.91 per patient/d).
Conclusions:
The COHERENT model is a new, easy-to-interpret, visual display of composite endpoints, enabling comparisons between patient groups and cohorts, including related costs. The model may constitute a useful new approach for clinical trials or observational studies, and a tool for benchmarking, and value-based health care implementation.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Pathophysiology of Heart Failure
Heart Failure III: Clinical Manifestations